Interactions between antitumour agents and radiation and the expression of resistance.
Hill
B T
BT
Cellular Chemotherapy Laboratory, Imperial Cancer Research Fund, London, U.K.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004351:Drug Resistance; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy; D011878:Radiotherapy; D011879:Radiotherapy Dosage; D051381:Rats; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000528:radiation effects
D000970:Antineoplastic Agents